Artwork

Content provided by PER Spectives and PER® Spectives. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PER Spectives and PER® Spectives or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

S2 Ep13: Patient, Provider, and Caregiver Connection™: Developing Strategies to Improve Patient Access to Care for Thalassemia - Understanding Patient Challenges and the Role of Innovative Treatment

35:14
 
Share
 

Manage episode 390610169 series 2987803
Content provided by PER Spectives and PER® Spectives. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PER Spectives and PER® Spectives or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
This podcast explores the management of thalassemia with a focus on the disease burden, current therapy, and emerging gene therapy. Two faculty, Hanny Al-Samkari, MD, and Kevin H.M. Kuo, MD, MSc, FRCPC, discuss with each other and with a patient sharing their journey living with thalassemia.
Faculty
Hanny Al-Samkari, MD
Classical Hematologist and Clinical Investigator
Division of Hematology Oncology
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, MA
Kevin H.M. Kuo, MD, MSc, FRCPC
Clinician-Investigator and Clinical Lead
Red Blood Cell Disorders Program
Division of Medical Oncology and Hematology
Department of Medicine
University Health Network
Associate Professor
Division of Hematology
Department of Medicine
Assistant Professor (status)
Institute of Health Policy
Management and Evaluation
Dalla Lana School of Public Health
University of Toronto
Toronto, Canada
  continue reading

27 episodes

Artwork
iconShare
 
Manage episode 390610169 series 2987803
Content provided by PER Spectives and PER® Spectives. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PER Spectives and PER® Spectives or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
This podcast explores the management of thalassemia with a focus on the disease burden, current therapy, and emerging gene therapy. Two faculty, Hanny Al-Samkari, MD, and Kevin H.M. Kuo, MD, MSc, FRCPC, discuss with each other and with a patient sharing their journey living with thalassemia.
Faculty
Hanny Al-Samkari, MD
Classical Hematologist and Clinical Investigator
Division of Hematology Oncology
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
Boston, MA
Kevin H.M. Kuo, MD, MSc, FRCPC
Clinician-Investigator and Clinical Lead
Red Blood Cell Disorders Program
Division of Medical Oncology and Hematology
Department of Medicine
University Health Network
Associate Professor
Division of Hematology
Department of Medicine
Assistant Professor (status)
Institute of Health Policy
Management and Evaluation
Dalla Lana School of Public Health
University of Toronto
Toronto, Canada
  continue reading

27 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide